PBM logo

Psyence Biomedical Ltd.

PBM
Healthcare|Biotechnology|CA
$2.96
+0.02 (+0.68%)
DCF Value
$9.82
Tangible Book / Share
$30.68
Cash / Share
$13.48
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Aug 26, 2026 (F-3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
Oct 21, 2026 · GlobeNewsWire
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
Oct 5, 2026 · GlobeNewsWire
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
Sep 28, 2026 · GlobeNewsWire
Psyence BioMed Announces Strategic Ibogaine Investment
Sep 23, 2026 · GlobeNewsWire
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
Sep 14, 2026 · GlobeNewsWire
Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development
Aug 18, 2026 · GlobeNewsWire

SEC Filings (90)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 21, 20266-KForeign issuer reportDocumentIndex
Oct 15, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Oct 5, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 5, 20266-KForeign issuer reportDocumentIndex
Sep 28, 20266-KForeign issuer reportDocumentIndex
Sep 23, 20266-KForeign issuer reportDocumentIndex
Sep 14, 20266-KForeign issuer reportDocumentIndex
Sep 1, 2026EFFECTDocumentIndex
Aug 26, 2026S-8Employee stock planDocumentIndex
Aug 26, 2026F-3Shelf registrationDocumentIndex
Aug 6, 20266-KForeign issuer reportDocumentIndex
Jun 22, 202620-FAnnual report (foreign)DocumentIndex
Jun 10, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 5, 20266-KForeign issuer reportDocumentIndex
Jun 3, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Apr 23, 20266-KForeign issuer reportDocumentIndex
Apr 20, 20266-KForeign issuer reportDocumentIndex
Apr 17, 20266-KForeign issuer reportDocumentIndex
Apr 15, 20266-KForeign issuer reportDocumentIndex
Mar 2, 20266-KForeign issuer reportDocumentIndex
Feb 20, 20266-KForeign issuer reportDocumentIndex
Feb 19, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 19, 20266-KForeign issuer reportDocumentIndex
Feb 13, 20266-KForeign issuer reportDocumentIndex
Feb 12, 20266-KForeign issuer reportDocumentIndex
Jan 29, 20266-KForeign issuer reportDocumentIndex
Jan 27, 20266-KForeign issuer reportDocumentIndex
Jan 14, 20266-KForeign issuer reportDocumentIndex
Jan 13, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jan 13, 20266-KForeign issuer reportDocumentIndex
Jan 13, 20266-K/AForeign issuer reportDocumentIndex
Jan 8, 20266-KForeign issuer reportDocumentIndex
Dec 10, 2025SC 13DActivist / 5%+ stakeDocumentIndex
Nov 21, 20256-KForeign issuer reportDocumentIndex
Nov 20, 2025424B3Offering prospectusDocumentIndex
Nov 20, 20256-KForeign issuer reportDocumentIndex
Nov 12, 2025424B3Offering prospectusDocumentIndex
Nov 10, 20256-KForeign issuer reportDocumentIndex
Nov 3, 2025424B3Offering prospectusDocumentIndex
Oct 14, 2025F-1/AIPO / offering registrationDocumentIndex